Follow
David Fenard
David Fenard
Executive / Senior Director - R&D / Cell Engineering, Sangamo Therapeutics
Verified email at sangamo.com
Title
Cited by
Cited by
Year
Prostratin antagonizes HIV latency by activating NF-κB
SA Williams, LF Chen, H Kwon, D Fenard, D Bisgrove, E Verdin, ...
Journal of Biological Chemistry 279 (40), 42008-42017, 2004
4022004
Secreted phospholipases A2, a new class of HIV inhibitors that block virus entry into host cells
D Fenard, G Lambeau, E Valentin, JC Lefebvre, M Lazdunski, A Doglio
The Journal of clinical investigation 104 (5), 611-618, 1999
2001999
Nef is physically recruited into the immunological synapse and potentiates T cell activation early after TCR engagement
D Fenard, W Yonemoto, C de Noronha, M Cavrois, SA Williams, ...
The Journal of Immunology 175 (9), 6050-6057, 2005
1512005
A peptide derived from bee venom-secreted phospholipase A2 inhibits replication of T-cell tropic HIV-1 strains via interaction with the CXCR4 chemokine receptor
D Fenard, G Lambeau, T Maurin, JC Lefebvre, A Doglio
Molecular pharmacology 60 (2), 341-347, 2001
1092001
Human immunodeficiency virus fusion to dendritic cells declines as cells mature
M Cavrois, J Neidleman, JF Kreisberg, D Fenard, C Callebaut, ...
Journal of virology 80 (4), 1992-1999, 2006
972006
HIV-1 virion fusion assay: uncoating not required and no effect of Nef on fusion
M Cavrois, J Neidleman, W Yonemoto, D Fenard, WC Greene
Virology 328 (1), 36-44, 2004
912004
Vectofusin-1, a new viral entry enhancer, strongly promotes lentiviral transduction of human hematopoietic stem cells
D Fenard, D Ingrao, A Seye, J Buisset, S Genries, S Martin, A Kichler, ...
Molecular Therapy-Nucleic Acids 2, e90, 2013
832013
Rodent cells support key functions of the human immunodeficiency virus type 1 pathogenicity factor Nef
OT Keppler, I Allespach, L Schüller, D Fenard, WC Greene, OT Fackler
Journal of virology 79 (3), 1655-1665, 2005
552005
VSV-G pseudotyping rescues HIV-1 CA mutations that impair core assembly or stability
S Brun, M Solignat, B Gay, E Bernard, L Chaloin, D Fenard, C Devaux, ...
Retrovirology 5 (1), 1-15, 2008
522008
Molecular determinants of vectofusin-1 and its derivatives for the enhancement of lentivirally mediated gene transfer into hematopoietic stem/progenitor cells
S Majdoul, AK Seye, A Kichler, N Holic, A Galy, B Bechinger, D Fenard
Journal of Biological Chemistry 291 (5), 2161-2169, 2016
432016
Concurrent measures of fusion and transduction efficiency of primary CD34+ cells with human immunodeficiency virus 1-based lentiviral vectors reveal different effects of …
D Ingrao, S Majdoul, AK Seye, A Galy, D Fenard
Human gene therapy methods 25 (1), 48-56, 2014
352014
Vectofusin-1, a potent peptidic enhancer of viral gene transfer forms pH-dependent α-helical nanofibrils, concentrating viral particles
LS Vermeer, L Hamon, A Schirer, M Schoup, J Cosette, S Majdoul, ...
Acta biomaterialia 64, 259-268, 2017
342017
Uracil DNA Glycosylase 2 negatively regulates HIV-1 LTR transcription
D Fenard, L Houzet, E Bernard, A Tupin, S Brun, M Mougel, C Devaux, ...
Nucleic acids research 37 (18), 6008-6018, 2009
342009
Baboon envelope LVs efficiently transduced human adult, fetal, and progenitor T cells and corrected SCID-X1 T-cell deficiency
O Bernadin, F Amirache, A Girard-Gagnepain, RD Moirangthem, C Lévy, ...
Blood advances 3 (3), 461-475, 2019
292019
Method for producing enveloped viruses
D Fenard
US Patent App. 10/125,352, 2018
29*2018
Influence of mildly acidic pH conditions on the production of lentiviral and retroviral vectors
N Holic, AK Seye, S Majdoul, S Martin, OW Merten, A Galy, D Fenard
Human Gene Therapy Clinical Development 25 (3), 178-185, 2014
262014
Vpr expression abolishes the capacity of HIV-1 infected cells to repair uracilated DNA
P Eldin, N Chazal, D Fenard, E Bernard, JF Guichou, L Briant
Nucleic acids research 42 (3), 1698-1710, 2014
262014
Infectivity enhancement of different HIV-1-based lentiviral pseudotypes in presence of the cationic amphipathic peptide LAH4-L1
D Fenard, S Genries, D Scherman, A Galy, S Martin, A Kichler
Journal of virological methods 189 (2), 375-378, 2013
252013
Preclinical assessment of antigen-specific chimeric antigen receptor regulatory T cells for use in solid organ transplantation
E Proics, M David, M Mojibian, M Speck, N Lounnas-Mourey, ...
Gene Therapy 30 (3), 309-322, 2023
232023
Vectofusin-1 Promotes RD114-TR-Pseudotyped Lentiviral Vector Transduction of Human HSPCs and T Lymphocytes
C Piovan, V Marin, C Scavullo, S Corna, E Giuliani, S Bossi, A Galy, ...
Molecular Therapy-Methods & Clinical Development 5, 22-30, 2017
192017
The system can't perform the operation now. Try again later.
Articles 1–20